Lack of neuroprotection against experimental glaucoma in c-Jun N-terminal kinase 3 knockout mice

Experimental Eye Research

Volumn 92, Issue 4, 2011, Pages 299-305

  Quigley, Harry A ^a   Cone, Frances E ^a   Gelman, Scott E ^a   Yang, Zhiyong ^a   Son, Janice L ^a   Oglesby, Ericka N ^a   Pease, Mary E ^a   Zack, Donald J ^a  

^a JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

C Jun N terminal kinase; Glaucoma; Neuroprotection; Pathogenesis; Retinal ganglion cell

Indexed keywords

GAMMA SYNUCLEIN; MITOGEN ACTIVATED PROTEIN KINASE 10;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY LABELING; ARTICLE; C57BL 6 MOUSE; CELL COUNT; CELL LOSS; CONFOCAL MICROSCOPY; CONTROLLED STUDY; FEMALE; GLAUCOMA; HISTOPATHOLOGY; INTRAOCULAR PRESSURE; KNOCKOUT MOUSE; MALE; MOUSE; NERVE FIBER; NEUROPROTECTION; NONHUMAN; OPTIC NERVE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; RETINA; RETINA AMACRINE CELL; RETINA GANGLION CELL; THICKNESS; WESTERN BLOTTING;

AMACRINE CELLS; ANIMALS; AXIAL LENGTH, EYE; AXONS; BLOTTING, WESTERN; CELL COUNT; CYTOPROTECTION; DISEASE MODELS, ANIMAL; GLAUCOMA; INTRAOCULAR PRESSURE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MICROSCOPY, CONFOCAL; MITOGEN-ACTIVATED PROTEIN KINASE 10; OCULAR HYPERTENSION; OPTIC NERVE DISEASES; RETINA; RETINAL GANGLION CELLS; SYNUCLEINS; TONOMETRY, OCULAR;

EID: 79952617170     PISSN: 00144835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.exer.2011.01.006     Document Type: Article

References (37)

1. Bessero A.-C., Chiodini F., Rungger-Brändle E., Bonny C., Clarke P.G.H. Role of the c-Jun N-terminal kinase pathway in retinal excitotoxicity, and neuroprotection by its inhibition. J. Neurochem. 2010, 5:1307-1318.
2. Bjorkblom B., Vainio J.C., Hongisto V., Herdegen T., Courtney M.J., Coffey E.T. All JNKs can kill, but nuclear localization is critical for neuronal death. J. Biol. Chem. 2008, 283:19704-19713.
3. Blair M., Pease M.E., Hammond J., Valenta D., Kielczewski J., Levkovitch-Verbin H., Quigley H.A. Effect of glatiramer acetate on primary and secondary degeneration of retinal ganglion cells in the rat. Invest. Ophthalmol. Vis. Sci. 2005, 46:884-890.
4. Cavalli V., Kujala P., Klumperman J., Goldstein L.S.B. Sunday driver links axonal transport to damage signaling. J. Cell. Biol. 2005, 168:775-787.
5. Chen L., Wu W., Dentchev T., Zeng Y., Want J., Tsui I., Tobias J.W., Bennett J., Baldwin D., Dunaief J. Light damage induced changes in mouse retinal gene expression. Exp. Eye Res. 2004, 79:239-247.
6. Choi W.-S., Abel G., Klintworth H., Flavell R.A., Xia Z. JNK3 mediates paraquat- and rotenone-induced dopaminergic neuron death. J. Neuropathol. Exp. Neurol. 2010, 69:511-520.
7. Cone F.E., Gelman S.E., Son J.L., Pease M.E., Quigley H.A. Differential susceptibility to experimental glaucoma among 3 mouse strains using bead and viscoelastic injection. Exp. Eye Res. 2010, 2010, Jun 26 (Epub ahead of print).
8. De Lemos L., Junyent F., Verdaguer E., Folch J., Romero R., Pallas M., et al. Differences in activation of ERK1/2 and p38 kinase in Jnk3 null mice following KA treatment. J. Neurochem 2010, 10.1111/j.1471-4159.2010.06853.x.
9. Eilers A., Whitfield J., Shah B., Spadoni C., Desmond H., Ham J. Direct inhibition of c-Jun N-terminal kinase in sympathetic neurons prevents c-jun promoter activation and NGF withdrawal-induced death. J. Neurochem. 2001, 76:1439-1454.
10. Fischer D., Petkova V., Thanos S., Benowitz L.J. Switching mature retinal ganglion cells to a robust growth state in vivo: gene expression and synergy with RhoA inactivation. J. Neurosci. 2004, 24:8726-8740.
11. Haeusgen W., Boehm R., Zhao Y., Herdegen T., Waetzig V. Specific activities of individual c-Jun N-terminal kinases in the brain. Neuroscience 2009, 161:951-959.
12. Hanz S., Fainzilber M. Retrograde signaling in injured nerve-the axon reaction revisited. J. Neurochem. 2006, 99:13-19.
13. Herdegen T., Claret F.X., Kallunki T., et al. Lasting N-terminal phosphorylation of c-Jun and activation of c-Jun N-terminal kinases after neuronal injury. J. Neurosci. 1998, 18:5124-5135.
14. Jakobs T.C., Libby R.T., Ben Y.U., John S.W.M., Masland R.H. Retinal ganglion cell degeneration is topological but not cell type specific in DBA/2J mice. J. Cell. Biol. 2005, 171:313-325.
15. Jeon C.J., Strettoi E., Masland R.H. The major cell populations of the mouse retina. J. Neurosci. 1998, 18:8936-8946.
16. Keramaris E., Ruzhynsky V.A., Callaghan S.M., Wong E., Davis R.J., Flavell R., et al. Required roles of Bax and JNKs in central and peripheral nervous system death of retinoblastoma-deficient mice. J. Biol. Chem. 2008, 283:405-415.
17. Kielczewski J.L., Pease M.E., Quigley H.A. The effect of experimental glaucoma and optic nerve transection on amacrine cells in the rat retina. Invest. Ophthalmol. Vis. Sci. 2005, 46:3188-3196.
18. Kwong J.M., Caprioli J. Expression of phosphorylated c-Jun N-terminal protein kinase (JNK) in experimental glaucoma in rats. Exp. Eye Res. 2006, 82:576-582.
19. Levkovitch-Verbin H., Quigley H.A., Martin K.R., Harizman N., Valenta D.F., Pease M.E., Melamed S. The transcription factor c-Jun is activated in retinal ganglion cells in experimental rat glaucoma. Exp. Eye Res. 2005, 80:663-670.
20. Levkovitch-Verbin H., Dardik R., Harizman N., Nisgav Y., Vander S., Melamed S. Regulation of cell death and survival pathways in experimental glaucoma. Exp. Eye Res. 2007, 85:250-258.
21. Lindwall C., Kanje M. Retrograde axonal transport of JNK signaling molecules influence injury induced nuclear changes in p-c-Jun and ATF3 in adult rat sensory neurons. Mol. Cell Neurosci 2005, 29(2):269-282.
22. Morfini G.A., You Y.-M., Pollema S.L., Kaminska A., Liu K., Yoshioka K., et al. Pathogenic huntingtin inhibits fast axonal transport by activating JNK3 and phosphorylating kinesin. Nat. Neurosci. 2009, 16:864-871.
23. Okuno S., Saito A., Hayashi T., Chan P.H. The c-Jun N-terminal protein kinase signaling pathway mediates Bax activation and subsequent neuronal apoptosis through interaction with Bim after transient cerebral ischemia. J. Neurosci. 2004, 24:7879-7887.
24. Pease, M.E., Cone, F.E., Gelman, S.E., Son, J.L., Quigley, H.A., in press. Calibration of the TonoLab tonometer in mice with spontaneous or experimental glaucoma. Invest. Ophthalmol. Vis. Sci. Aug 18. [Epub ahead of print].
25. Ries V., Silva R.M., Oo T.F., Cheng H.-C., Rzhetskaya M., Kholodilov N., et al. JNK2 and JNK3 combined are essential for apoptosis in dopamine neurons of the substantia nigra, but are not required for axon degeneration. J. Neurochem. 2008, 107:1578-1588.
26. Salinas-Navarro M., Alarcón-Martínez L., Valente-Sonano F.J., Jiménez-López M., Mayor-Torroglosa S., Avilés-Trigueros M., Villegas-Pérez M.P., Vidal-Sanz M. Ocular hypertension impairs optic nerve axonal transport leading to progressive retinal ganglion cell degeneration. Exp. Eye Res. 2010, 90:168-183.
27. Seif G.I., Nomura H., Tator C.H. Retrograde axonal degeneration (dieback) in corticospinal tract after transaction injury of the rat spinal cord: a confocal microscopy study. J. Neurotrauma 2007, 24:1513-1528.
28. Sekine O., Nishio Y., Egamwa K., Nakamura T., Maegawa H., Kashiwagi A. Insulin activates CCAAT/enhancer binding proteins and proinflammatory gene expression through the phosphatidylinositol 3-kinase pathway in vascular smooth muscle cells. J. Biol. Chem. 2002, 2777:36631-36639.
29. Soto I., Oglesby E., Buckingham B.P., Son J.L., Roberson E.D., Steele M.R., Inman D.M., Vetter M.L., Horner P.J., Marsh-Armstrong N. Retinal ganglion cells downregulate gene expression and lose their axons within the optic nerve head in a mouse glaucoma model. J. Neurosci. 2008, 28:548-561.
30. Stagi M., Dittrich P.S., Frank N., Iliev A.I., Schwille P., Neumann H. Breakdown of axonal synaptic vesicle precursor transport by microglial nitric oxide. J. Neurosci. 2005, 25:352-362.
31. Takeda M., Kato H., Takamiya A., Yoshida A., Kiyama H. Injury-specific expression of activating transcription factor-3 in retinal ganglion cells and its colocalized expression with phosphorylated c-Jun. Invest. Ophthalmol. Vis. Sci. 2000, 41:2412-2421.
32. Tezel G., Hernandez M.R., Wax M.B. Immunostaining of heat shock proteins in the retina and optic nerve head of normal and glaucomatous eyes. Arch. Ophthalmol. 2000, 118:511-518.
33. Tezel G., Chauhan B.C., LeBlanc R.P., Wax M.B. Immunohistochemical assessment of the glial mitogen-activated protein kinase activation in glaucoma. Invest. Ophthalmol. Vis. Sci. 2003, 44:3025-3033.
34. Yang D.D., Kuan C.-Y., Whitmarsh A.J., Rincon M., Zhen T.S., Davis R.J., Rakic P., Flavell R.A. Absence of excitotoxicity-induced apoptosis in the hippocampus of mice lacking the JNK3 gene. Nature 1997, 389:865-870.
35. Yang Z., Quigley H.A., Pease M.E., Yang Y., Qian J., Valenta D., Zack D.J. Changes in gene expression in experimental glaucoma and optic nerve transection: The equilibrium between protective and detrimental mechanisms. Invest. Ophthalmol. Vis. Sci. 2007, 48:5539-5548.
36. Yasuda J., Whitmarsh A.J., Cavanagh J., Sharma M., Davis R.J. The JIP group of mitogen-activated protein kinase scaffold proteins. Mol. Cell. Biol. 1999, 19:7245-7254.
37. Zhao Y., Herdegen T. Cerebral ischemia provokes a profound exchange of activated JNK isoforms in brain mitochondria. Mol. Cell. Neurosci. 2009, 41:186-195.